A Fatal Case of Rhizopus azygosporus Pneumonia Following COVID-19

A Fatal Case of Rhizopus azygosporus Pneumonia Following COVID-19

Blog Article

We report a fatal case of Rhizopus azygosporus pneumonia in a 56-year-old man hospitalized for COVID-19 who had received methylprednisolone and tocilizumab.Although COVID-associated pulmonary aspergillosis Vanity has been widely documented, mucormycosis has been rarely reported.In this Anti-Vibration Mount patient, receipt of two commonly used immunosuppressants likely contributed to mucormycosis risk, suggesting the need for vigilance in hospitalized patients with COVID-19.